These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38860471)

  • 1. Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.
    Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Huang J; Bergström T; Kockum I; Waterboer T; Olsson T; Sundström P
    Ann Neurol; 2024 Aug; 96(2):302-305. PubMed ID: 38860471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.
    Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
    Front Immunol; 2019; 10():2715. PubMed ID: 32038605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients.
    Pérez-Pérez S; Cuello JP; Martínez-Ginés M; Pardo-Rodríguez B; García-Domínguez JM; Domínguez-Mozo MI; Lozano-Ros A; García-Martínez MÁ; Higueras Y; Meldaña-Rivera A; Goicochea-Briceño H; Tejeda-Velarde A; Fernández-Velasco JI; Medina S; Arroyo R; Villar LM; Álvarez-Lafuente R
    Sci Rep; 2021 Apr; 11(1):8441. PubMed ID: 33875702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
    Pérez-Pérez S; Domínguez-Mozo MI; García-Martínez MÁ; García-Frontini MC; Villarrubia N; Costa-Frossard L; Villar LM; Arroyo R; Álvarez-Lafuente R
    Front Immunol; 2021; 12():798003. PubMed ID: 34912348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
    Neurology; 2004 Jun; 62(12):2277-82. PubMed ID: 15210894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M; Leng Y; Bjornevik K; Mitchell M; Healy BC; Mina MJ; Mancuso JD; Niebuhr DW; Munger KL; Elledge SJ; Ascherio A
    JAMA Neurol; 2024 May; 81(5):515-524. PubMed ID: 38497939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis.
    Biström M; Jons D; Engdahl E; Gustafsson R; Huang J; Brenner N; Butt J; Alonso-Magdalena L; Gunnarsson M; Vrethem M; Bender N; Waterboer T; Granåsen G; Olsson T; Kockum I; Andersen O; Fogdell-Hahn A; Sundström P
    Eur J Neurol; 2021 Feb; 28(2):579-586. PubMed ID: 33065762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of EBV and HHV-6A on MS risk.
    Wood H
    Nat Rev Neurol; 2024 Aug; 20(8):456. PubMed ID: 38977879
    [No Abstract]   [Full Text] [Related]  

  • 14. Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
    Grut V; Biström M; Salzer J; Stridh P; Jons D; Gustafsson R; Fogdell-Hahn A; Huang J; Butt J; Lindam A; Alonso-Magdalena L; Bergström T; Kockum I; Waterboer T; Olsson T; Zetterberg H; Blennow K; Andersen O; Nilsson S; Sundström P
    Brain; 2024 Jan; 147(1):177-185. PubMed ID: 37930324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression
    Peddu V; Dubuc I; Gravel A; Xie H; Huang ML; Tenenbaum D; Jerome KR; Tardif JC; Dubé MP; Flamand L; Greninger AL
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
    Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
    J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.